Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer.

Bernhard GrubmüllerNicolai A HuebnerSazan RasulPaola ClauserNina PötschKarl Hermann GrubmüllerMarcus HackerSabrina HartenbachShahrokh F ShariatMarkus HartenbachPascal Baltzer

Published in: Current oncology (Toronto, Ont.) (2023)

Combined FMC+PSMA SUVmax seems to be a reliable parameter for the prediction of csPC and might overcome the limitations of PI-RADS scoring. Further prospective studies are necessary to confirm these promising preliminary results.

Keyphrases

prostate cancer
pet imaging
pet ct
positron emission tomography
high resolution
computed tomography
magnetic resonance imaging
radical prostatectomy
contrast enhanced
magnetic resonance
mass spectrometry